HPR152 Impact of Brexit-Induced Changes to Regulatory Approval on UK Access to Medicines

Abstract

Authors

A Shaw A Mooten J Gibson

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×